Epigenetic Modifications in Sensorineural Hearing Loss: Protective Mechanisms and Therapeutic Potential

Abstract

Hearing loss, which currently affects more than 430 million individuals globally and is projected to exceed 700 million by 2050, predominantly manifests as sensorineural hearing loss (SNHL), for which existing technologies such as hearing aids and cochlear implants fail to restore natural auditory function. Research focusing on protecting inner ear hair cells (HCs) from harmful factors through the regulation of epigenetic modifications has gained significant attention in otology for its role in regulating gene expression without altering the DNA sequence, suggesting potential strategies for preventing and treating SNHL. By synthesizing relevant studies on the inner ear, this review summarizes the emerging roles of histone modifications, DNA methylation, and noncoding RNAs in HC damage, with a focus on their therapeutic potential through epigenetic modulation. Moreover, this review examines the therapeutic potential of epigenetic regulation for the prevention and treatment of SNHL, emphasizing the application of small-molecule epigenetic compounds and their efficacy in modulating gene expression to preserve and restore auditory function.

Keywords

Sensorineural hearing loss / Hair cell protection / Epigenetic modification / Epigenetic compounds

References

[1] WilsonBS, TucciDL. Addressing the global burden of hearing loss. The Lancet., 2021, 397(10278): 945-947

[2] PayneT, WongG. Hearing loss: Conductive versus sensorineural. InnovAiT., 2022, 15(4): 218-225

[3] Zahnert T. The differential diagnosis of hearing loss. Dtsch Arztebl Int. 2011;108(25):433–443; quiz 44.

[4] KleinjungT, LonderoASchleeW, LangguthB, De RidderD, VannesteS, KleinjungT, MøllerAR. Conductive and Sensorineural Hearing Loss. Textbook of Tinnitus, 2024, Cham, Springer International Publishing: 385-398

[5] BingX, LiuC, CaoX, et al.. Development of the inner ear and regeneration of hair cells after hearing impairment. Fundamental Research., 2025, 5(1): 203-214

[6] BurnsJC, CorwinJT. A historical to present-day account of efforts to answer the question:“what puts the brakes on mammalian hair cell regeneration?”. Hear Res., 2013, 297: 52-67

[7] LiuCC, AnneS, HornDL. Advances in Management of Pediatric Sensorineural Hearing Loss. Otolaryngol Clin North Am., 2019, 52(5): 847-861

[8] WagnerEL, ShinJB. Mechanisms of Hair Cell Damage and Repair. Trends Neurosci., 2019, 42(6): 414-424

[9] WangK, LiuH, HuQ, et al.. Epigenetic regulation of aging: implications for interventions of aging and diseases. Signal Transduct Target Ther., 2022, 7(1): 374

[10] ChenC, WangJ, ZhangS, et al.. Epigenetic regulation of diverse regulated cell death modalities in cardiovascular disease: Insights into necroptosis, pyroptosis, ferroptosis, and cuproptosis. Redox Biol., 2024, 76 103321

[11] WaddingtonCH. The Epigenotype. Int J Epidemiol., 2011, 41(1): 10-13

[12] BuschdorfJP, SträtlingWH. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. J Mol Med (Berl)., 2004, 82(2): 135-143

[13] HirokawaY, NakajimaH, HanemannCO, et al.. Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228. Cancer Biol Ther., 2005, 4(4): 379-381

[14] SageC, HuangM, VollrathMA, et al.. Essential role of retinoblastoma protein in mammalian hair cell development and hearing. Proc Natl Acad Sci U S A., 2006, 103(19): 7345-7350

[15] HeY, ZhengZ, LiuC, et al.. Inhibiting DNA methylation alleviates cisplatin-induced hearing loss by decreasing oxidative stress-induced mitochondria-dependent apoptosis via the LRP1-PI3K/AKT pathway. Acta Pharm Sin B., 2022, 12(3): 1305-1321

[16] ZhengZ, ZengS, LiuC, et al.. The DNA methylation inhibitor RG108 protects against noise-induced hearing loss. Cell Biol Toxicol., 2021, 37(5): 751-771

[17] de Sá JuniorPL, CâmaraDAD, PorcacchiaAS, et al.. The Roles of ROS in Cancer Heterogeneity and Therapy. Oxid Med Cell Longev., 2017, 2017: 2467940

[18] LiuZY, SongK, TuB, et al.. Crosstalk between oxidative stress and epigenetic marks: New roles and therapeutic implications in cardiac fibrosis. Redox Biol., 2023, 65 102820

[19] Millán-ZambranoG, BurtonA, BannisterAJ, et al.. Histone posttranslational modifications - cause and consequence of genome function. Nat Rev Genet., 2022, 23(9): 563-580

[20] LiuM, ZhangK, LiQ, et al.. Recent advances on small-molecule bromodomain-containing histone acetyltransferase inhibitors. Journal of Medicinal Chemistry., 2023, 66(3): 1678-1699

[21] Gonzales-CopeM, SidoliS, BhanuNV, et al.. Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells. BMC Genomics., 2016, 17: 95

[22] LeRoyG, RickardsB, FlintSJ. The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Mol Cell., 2008, 30(1): 51-60

[23] HaberlandM, MontgomeryRL, OlsonEN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet., 2009, 10(1): 32-42

[24] ShvedunovaM, AkhtarA. Modulation of cellular processes by histone and nonhistone protein acetylation. Nat Rev Mol Cell Biol., 2022, 23(5): 329-349

[25] KabirF, AtkinsonR, CookAL, et al.. The role of altered protein acetylation in neurodegenerative disease. Frontiers in Aging Neuroscience., 2023, 14: 1025473

[26] ShuklaS, TekwaniBL. Histone Deacetylases Inhibitors in Neurodegenerative Diseases, Neuroprotection and Neuronal Differentiation. Front Pharmacol., 2020, 11: 537

[27] BaierD, MendrinaT, Schoenhacker-AlteB, et al.. The Lipid Metabolism as Target and Modulator of BOLD-100 Anticancer Activity: Crosstalk with Histone Acetylation. Adv Sci (Weinh)., 2023, 10(32): e2301939

[28] MahlknechtU, HoelzerD. Histone acetylation modifiers in the pathogenesis of malignant disease. Mol Med., 2000, 6(8): 623-644

[29] GaoP, YouM, LiL, et al.. Salt-Induced Hepatic Inflammatory Memory Contributes to Cardiovascular Damage Through Epigenetic Modulation of SIRT3. Circulation., 2022, 145(5): 375-391

[30] DaskalakiMG, TsatsanisC, KampranisSC. Histone methylation and acetylation in macrophages as a mechanism for regulation of inflammatory responses. J Cell Physiol., 2018, 233(9): 6495-6507

[31] LaymanWS, WilliamsDM, DearmanJA, et al.. Histone deacetylase inhibition protects hearing against acute ototoxicity by activating the Nf-κB pathway. Cell Death Discov., 2015, 1: 15012

[32] WenLT, WangJ, WangY, et al.. Association between histone deacetylases and the loss of cochlear hair cells: Role of the former in noise-induced hearing loss. Int J Mol Med., 2015, 36(2): 534-540

[33] NamYS, GiEJ, KoYS, et al.. Trichostatin A suppresses hearing loss by reducing oxidative stress and inflammation in an Alport syndrome model. PLoS One., 2025, 20(2): e0316033

[34] KeeHJ, KimI, JeongMH. Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension. Biochemical Pharmacology., 2022, 202 115111

[35] CaoC, WuH, VasilatosSN, et al.. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells. Int J Cancer., 2018, 143(6): 1388-1401

[36] WangJ, TianKY, FangY, et al.. Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression. Int J Immunopathol Pharmacol., 2021, 35: 20587384211034086

[37] RybakLP, AlbertsI, PatelS, et al.. Effects of natural products on cisplatin ototoxicity and chemotherapeutic efficacy. Expert Opin Drug Metab Toxicol., 2023, 19(9): 635-652

[38] SealyL, ChalkleyR. The effect of sodium butyrate on histone modification. Cell., 1978, 14(1): 115-121

[39] DrottarM, LibermanMC, RatanRR, et al.. The histone deacetylase inhibitor sodium butyrate protects against cisplatin-induced hearing loss in guinea pigs. Laryngoscope., 2006, 116(2): 292-296

[40] ChenFQ, SchachtJ, ShaSH. Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea. J Neurochem., 2009, 108(5): 1226-1236

[41] WangJ, WangY, ChenX, et al.. Histone deacetylase inhibitor sodium butyrate attenuates gentamicin-induced hearing loss in vivo. Am J Otolaryngol., 2015, 36(2): 242-248

[42] YangDH, XieJ, LiuK, et al.. The histone deacetylase inhibitor sodium butyrate protects against noise-induced hearing loss in Guinea pigs. Neurosci Lett., 2017, 660: 140-146

[43] ChenJ, HillK, ShaSH. Inhibitors of Histone Deacetylases Attenuate Noise-Induced Hearing Loss. J Assoc Res Otolaryngol., 2016, 17(4): 289-302

[44] YangCH, LiuZ, DongD, et al.. Histone Deacetylase Inhibitors Are Protective in Acute but Not in Chronic Models of Ototoxicity. Front Cell Neurosci., 2017, 11: 315

[45] FanB, WangJ, ZhaD, et al.. ATP depletion induced cochlear hair cells death through histone deacetylation in vitro. Neurosci Lett., 2020, 727 134918

[46] HuangJ, WangP, LiM, et al.. Trichostatin A reduces cisplatin-induced ototoxicity through the STAT6 signaling pathway. Int J Mol Med., 2015, 36(2): 493-500

[47] WangP, ZhangP, HuangJ, et al.. Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function. Neurotoxicology., 2013, 37: 51-62

[48] NamYS, ChoiYM, LeeS, et al.. Valproic Acid Inhibits Progressive Hereditary Hearing Loss in a KCNQ4 Variant Model through HDAC1 Suppression. Int J Mol Sci., 2023, 24(6): 5695

[49] ArmonC, BrownE, CarwileS, et al.. Sensorineural hearing loss: a reversible effect of valproic acid. Neurology., 1990, 40(12): 1896-1898

[50] HoriA, KataokaS, SakaiK, et al.. Valproic acid-induced hearing loss and tinnitus. Intern Med., 2003, 42(11): 1153-1154

[51] YeapLL, LimKS, LoYL, et al.. Valproate-induced reversible sensorineural hearing loss: a case report with serial audiometry and pharmacokinetic modeling during a valproate rechallenge. Epileptic Disord., 2014, 16(3): 375-379

[52] IncecikF, AkogluE, SangünO, et al.. Effects of valproic acid on hearing in epileptic patients. Int J Pediatr Otorhinolaryngol., 2007, 71(4): 611-614

[53] WuQJ, ZhangTN, ChenHH, et al.. The sirtuin family in health and disease. Signal Transduct Target Ther., 2022, 7(1): 402

[54] SeidmanM, BabuS, TangW, et al.. Effects of resveratrol on acoustic trauma. Otolaryngol Head Neck Surg., 2003, 129(5): 463-470

[55] XiongH, OuY, XuY, et al.. Resveratrol Promotes Recovery of Hearing following Intense Noise Exposure by Enhancing Cochlear SIRT1 Activity. Audiol Neurootol., 2017, 22(4–5): 303-310

[56] ChenXM, LiuYH, JiSF, et al.. Protective effect of ginsenoside Rd on military aviation noise-induced cochlear hair cell damage in guinea pigs. Environ Sci Pollut Res Int., 2023, 30(9): 23965-23981

[57] KhoshsiratS, AbbaszadehHA, PeyvandiAA, et al.. Apelin-13 prevents apoptosis in the cochlear tissue of noise-exposed rat via Sirt-1 regulation. J Chem Neuroanat., 2021, 114 101956

[58] PangJ, XiongH, ZhanT, et al.. Sirtuin 1 and Autophagy Attenuate Cisplatin-Induced Hair Cell Death in the Mouse Cochlea and Zebrafish Lateral Line. Front Cell Neurosci., 2018, 12: 515

[59] KimHJ, OhGS, ShenA, et al.. Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment. Cell Death Dis., 2014, 5(6): e1292

[60] FangJ, WuH, ZhangJ, et al.. A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation. Biomed Pharmacother., 2022, 150 113071

[61] DingD, QiW, YuD, et al.. Addition of exogenous NAD+ prevents mefloquine-induced neuroaxonal and hair cell degeneration through reduction of caspase-3-mediated apoptosis in cochlear organotypic cultures. PLoS One., 2013, 8(11): e79817

[62] XiongH, DaiM, OuY, et al.. SIRT1 expression in the cochlea and auditory cortex of a mouse model of age-related hearing loss. Exp Gerontol., 2014, 51: 8-14

[63] PangJ, XiongH, OuY, et al.. SIRT1 protects cochlear hair cell and delays age-related hearing loss via autophagy. Neurobiol Aging., 2019, 80: 127-137

[64] AffortitC, CasasF, LadrechS, et al.. Exacerbated age-related hearing loss in mice lacking the p43 mitochondrial T3 receptor. BMC Biol., 2021, 19(1): 18

[65] ZhaoC, YangZ, GongS, et al.. Adenovirus-mediated SIRT1 protects cochlear strial marginal cells in a D-gal-induced senescent model in vitro. Mol Biol Rep., 2023, 50(1): 541-551

[66] HanC, LinserP, ParkHJ, et al.. Sirt1 deficiency protects cochlear cells and delays the early onset of age-related hearing loss in C57BL/6 mice. Neurobiol Aging., 2016, 43: 58-71

[67] Rivas-Chacón LDM, Yanes-Díaz J, de Lucas B, et al. Cocoa Polyphenol Extract Inhibits Cellular Senescence via Modulation of SIRT1 and SIRT3 in Auditory Cells. Nutrients. 2023;15(3):544

[68] ZhengZ, ZhangP, FuY, et al.. The potential role of the SIRT1-Nrf2 signaling pathway in alleviating hidden hearing loss via antioxidant stress. Cell Biol Int., 2025, 49(3): 262-276

[69] LiuY, AoL, LiY, et al.. The SIRT2 inhibitor AK-7 decreases cochlear cell apoptosis and attenuates noise-induced hearing loss. Biochem Biophys Res Commun., 2019, 509(3): 641-646

[70] Wang Y, Yang J, Hong T, et al. SIRT2: Controversy and multiple roles in disease and physiology. Aging Res Rev. 2019;55:100961.

[71] PengF, LiaoM, JinW, et al.. 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis. Signal Transduct Target Ther., 2024, 9(1): 133

[72] BalabanRS, NemotoS, FinkelT. Mitochondria, oxidants, and aging. Cell., 2005, 120(4): 483-495

[73] ZouT, YeB, ChenK, et al.. Impacts of impaired mitochondrial dynamics in hearing loss: Potential therapeutic targets. Front Neurosci., 2022, 16 998507

[74] BrownKD, MaqsoodS, HuangJY, et al.. Activation of SIRT3 by the NAD⁺ precursor nicotinamide riboside protects from noise-induced hearing loss. Cell Metab., 2014, 20(6): 1059-1068

[75] CantóC, HoutkooperRH, PirinenE, et al.. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab., 2012, 15(6): 838-847

[76] HanH, DongY, MaX. Dihydromyricetin Protects Against Gentamicin-Induced Ototoxicity via PGC-1α/SIRT3 Signaling in vitro. Front Cell Dev Biol., 2020, 8: 702

[77] HuY, MaX. Icariin Treatment Protects Against Gentamicin-Induced Ototoxicity via Activation of the AMPK-SIRT3 Pathway. Front Pharmacol., 2021, 12 620741

[78] ZhangY, LiQ, HanC, et al.. Superoxide dismutase@zeolite Imidazolate Framework-8 Attenuates Noise-Induced Hearing Loss in Rats. Front Pharmacol., 2022, 13 885113

[79] LiangW, ZhaoC, ChenZ, et al.. Sirtuin-3 Protects Cochlear Hair Cells Against Noise-Induced Damage via the Superoxide Dismutase 2/Reactive Oxygen Species Signaling Pathway. Front Cell Dev Biol., 2021, 9 766512

[80] QuanY, XiaL, ShaoJ, et al.. Adjudin protects rodent cochlear hair cells against gentamicin ototoxicity via the SIRT3-ROS pathway. Sci Rep., 2015, 5: 8181

[81] TanX, ZhouY, AgarwalA, et al.. Systemic application of honokiol prevents cisplatin ototoxicity without compromising its antitumor effect. Am J Cancer Res., 2020, 10(12): 4416-4434

[82] DuP, LiuT, LuoP, et al.. SIRT3/GLUT4 signaling activation by metformin protect against cisplatin-induced ototoxicity in vitro. Arch Toxicol., 2023, 97(4): 1147-1162

[83] TianG, SawashitaJ, KuboH, et al.. Ubiquinol-10 supplementation activates mitochondria functions to decelerate senescence in senescence-accelerated mice. Antioxid Redox Signal., 2014, 20(16): 2606-2620

[84] MiwaT. Protective Effects of N(1)-Methylnicotinamide Against High-Fat Diet- and Age-Induced Hearing Loss via Moderate Overexpression of Sirtuin 1 Protein. Front Cell Neurosci., 2021, 15 634868

[85] ZhangL, DuZ, HeL, et al.. ROS-Induced Oxidative Damage and Mitochondrial Dysfunction Mediated by Inhibition of SIRT3 in Cultured Cochlear Cells. Neural Plast., 2022, 2022: 5567174

[86] ZhaoC, LiangW, YangZ, et al.. SIRT3-mediated deacetylation protects inner hair cell synapses in a H(2)O(2)-induced oxidative stress model in vitro. Exp Cell Res., 2022, 418(2): 113280

[87] SomeyaS, YuW, HallowsWC, et al.. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell., 2010, 143(5): 802-812

[88] Patel S, Shah L, Dang N, et al, White PM. SIRT3 promotes auditory function in young adult FVB/nJ mice but is dispensable for hearing recovery after noise exposure. PLoS One. 2020;15(7):e0235491.

[89] DingD, ProllaT, SomeyaS, et al.. Roles of Bak and Sirt3 in Paraquat-Induced Cochlear Hair Cell Damage. Neurotox Res., 2021, 39(4): 1227-1237

[90] LeeSC, AdamsDW, IpsaroJJ, et al.. Chromatin remodeling of histone H3 variants by DDM1 underlies epigenetic inheritance of DNA methylation. Cell., 2023, 186(19): 4100-4116.e15

[91] BarskiA, CuddapahS, CuiK, et al.. High-resolution profiling of histone methylations in the human genome. Cell., 2007, 129(4): 823-837

[92] YuH, LinQ, WangY, et al.. Inhibition of H3K9 methyltransferases G9a/GLP prevents ototoxicity and ongoing hair cell death. Cell Death Dis., 2013, 4(2): e506

[93] XiongH, LongH, PanS, et al.. Inhibition of Histone Methyltransferase G9a Attenuates Noise-Induced Cochlear Synaptopathy and Hearing Loss. J Assoc Res Otolaryngol., 2019, 20(3): 217-232

[94] MuYR, ZouSY, LiM, et al.. Role and mechanism of FOXG1-related epigenetic modifications in cisplatin-induced hair cell damage. Front Mol Neurosci., 2023, 16: 1064579

[95] MetzgerE, WissmannM, YinN, et al.. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature., 2005, 437(7057): 436-439

[96] HeY, YuH, CaiC, et al.. Inhibition of H3K4me2 Demethylation Protects Auditory Hair Cells from Neomycin-Induced Apoptosis. Mol Neurobiol., 2015, 52(1): 196-205

[97] LiA, YouD, LiW, et al.. Novel compounds protect auditory hair cells against gentamycin-induced apoptosis by maintaining the expression level of H3K4me2. Drug Deliv., 2018, 25(1): 1033-1043

[98] LiuC, ZhengZ, LiW, et al.. Inhibition of KDM5A attenuates cisplatin-induced hearing loss via regulation of the MAPK/AKT pathway. Cell Mol Life Sci., 2022, 79(12): 596

[99] LiX, ChenX. Inhibition of PRMT6 reduces neomycin-induced inner ear hair cell injury through the restraint of FoxG1 arginine methylation. Inflamm Res., 2022, 71(3): 309-320

[100] ZhaoB, ZhangD, SunY, et al.. Explore the effect of LLY-283 on the ototoxicity of auditory cells caused by cisplatin: A bioinformatic analysis based on RNA-seq. J Clin Lab Anal., 2022, 36(2): e24176

[101] HeZH, LiM, FangQJ, et al.. FOXG1 promotes aging inner ear hair cell survival through activation of the autophagy pathway. Autophagy., 2021, 17(12): 4341-4362

[102] HeY, LiW, ZhengZ, et al.. Inhibition of Protein arginine methyltransferase 6 reduces reactive oxygen species production and attenuates aminoglycoside- and cisplatin-induced hair cell death. Theranostics., 2020, 10(1): 133-150

[103] ParryA, RulandsS, ReikW. Active turnover of DNA methylation during cell fate decisions. Nat Rev Genet., 2021, 22(1): 59-66

[104] MooreLD, LeT, FanG. DNA methylation and its basic function. Neuropsychopharmacology., 2013, 38(1): 23-38

[105] LiS, PengY, PanchenkoAR. DNA methylation: Precise modulation of chromatin structure and dynamics. Current opinion in structural biology., 2022, 75 102430

[106] ListerR, PelizzolaM, DowenRH, et al.. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature., 2009, 462(7271): 315-322

[107] AndrewsS, KruegerC, Mellado-LopezM, et al.. Mechanisms and function of de novo DNA methylation in placental development reveals an essential role for DNMT3B. Nat Commun., 2023, 14(1): 371

[108] OkanoM, BellDW, HaberDA, et al.. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell., 1999, 99(3): 247-257

[109] SunZ, WuY, OrdogT, et al.. Aberrant signature methylome by DNMT1 hot spot mutation in hereditary sensory and autonomic neuropathy 1E. Epigenetics., 2014, 9(8): 1184-1193

[110] MarescaA, ZaffagniniM, CaporaliL, et al.. DNA methyltransferase 1 mutations and mitochondrial pathology: is mtDNA methylated?. Front Genet., 2015, 6: 90

[111] KernohanKD, Cigana SchenkelL, HuangL, et al.. Identification of a methylation profile for DNMT1-associated autosomal dominant cerebellar ataxia, deafness, and narcolepsy. Clin Epigenetics., 2016, 8(1): 91

[112] KleinCJ, BirdT, Ertekin-TanerN, et al.. DNMT1 mutation hot spot causes varied phenotypes of HSAN1 with dementia and hearing loss. Neurology., 2013, 80(9): 824-828

[113] KleinCJ, BotuyanMV, WuY, et al.. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet., 2011, 43(6): 595-600

[114] BouzidA, SmetiI, ChakrounA, et al.. CDH23 Methylation Status and Presbycusis Risk in Elderly Women. Front Aging Neurosci., 2018, 10: 241

[115] BouzidA, SmetiI, DhouibL, et al.. Downexpression of P2RX2, KCNQ5, ERBB3 and SOCS3 through DNA hypermethylation in elderly women with presbycusis. Biomarkers., 2018, 23(4): 347-356

[116] TisatoV, CastiglioneA, CiorbaA, et al.. LINE-1 global DNA methylation, iron homeostasis genes, sex and age in sudden sensorineural hearing loss (SSNHL). Hum Genomics., 2023, 17(1): 112

[117] MalikRE, RhodesSJ. The role of DNA methylation in regulation of the murine Lhx3 gene. Gene., 2014, 534(2): 272-281

[118] MutaiH, MiyaF, FujiiM, et al.. Attenuation of progressive hearing loss in DBA/2J mice by reagents that affect epigenetic modifications is associated with upregulation of the zinc importer Zip4. PLoS One., 2015, 10(4): e0124301

[119] SalahA, AlmannaiM, Al OjaimiM, et al.. A homozygous frame-shift variant in PROSER1 is associated with developmental delay, hypotonia, genitourinary malformations, and distinctive facial features. Clin Genet., 2022, 101(5–6): 565-570

[120] ZhengZ, NanB, LiuC, et al.. Inhibition of histone methyltransferase PRMT5 attenuates cisplatin-induced hearing loss through the PI3K/Akt-mediated mitochondrial apoptotic pathway. J Pharm Anal., 2023, 13(6): 590-602

[121] Koffler-BrillT, NoyY, AvrahamKB. The long and short: Noncoding RNAs in the mammalian inner ear. Hear Res., 2023, 428 108666

[122] LingH, FabbriM, CalinGA. MicroRNAs and other noncoding RNAs as targets for anticancer drug development. Nat Rev Drug Discov., 2013, 12(11): 847-865

[123] BartelDP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell., 2004, 116(2): 281-297

[124] MeisterG, LandthalerM, PatkaniowskaA, et al.. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell., 2004, 15(2): 185-297

[125] WestonMD, PierceML, Rocha-SanchezS, et al.. MicroRNA gene expression in the mouse inner ear. Brain Res., 2006, 1111(1): 95-104

[126] HiraiM, MaedaY, FukushimaK, et al.. Expression analysis of microRNAs in murine cochlear explants. Neuroreport., 2011, 22(13): 652-654

[127] PierceML, WestonMD, FritzschB, et al.. MicroRNA-183 family conservation and ciliated neurosensory organ expression. Evol Dev., 2008, 10(1): 106-113

[128] KimJ, LeeB, LeeS, et al.. Identification and Characterization of mRNA and lncRNA Expression Profiles in Age-Related Hearing Loss. Clin Exp Otorhinolaryngol., 2023, 16(2): 115-124

[129] WangN, LiuX, DingL, et al.. Analysis of lncRNA-mRNA expression pattern in male textile workers with noise-induced hearing loss. Ann Transl Med., 2019, 7(20): 569

[130] ZhaoT, LiuX, SunZ, et al.. RNA-seq analysis of potential lncRNAs for age-related hearing loss in a mouse model. Aging (Albany NY)., 2020, 12(8): 7491-7510

[131] LuoX, HuY, ZhouX, et al.. Potential roles for lncRNA Mirg/Foxp1 in an ARHL model created using C57BL/6J mice. Hear Res., 2023, 438 108859

[132] WeiW, ShiX, XiongW, et al.. RNA-seq Profiling and Coexpression Network Analysis of Long Noncoding RNAs and mRNAs Reveal Novel Pathogenesis of Noise-induced Hidden Hearing Loss. Neuroscience., 2020, 434: 120-135

[133] XiongH, PangJ, YangH, et al.. Activation of miR-34a/SIRT1/p53 signaling contributes to cochlear hair cell apoptosis: implications for age-related hearing loss. Neurobiol Aging., 2015, 36(4): 1692-1701

[134] WangH, LinH, KangW, et al.. miR-34a/DRP-1-mediated mitophagy participated in cisplatin-induced ototoxicity by increasing oxidative stress. BMC Pharmacol Toxicol., 2023, 24(1): 16

[135] XueT, WeiL, ZhaDJ, et al.. miR-29b overexpression induces cochlear hair cell apoptosis through the regulation of SIRT1/PGC-1α signaling: Implications for age-related hearing loss. Int J Mol Med., 2016, 38(5): 1387-1394

[136] HaoS, WangL, ZhaoK, et al.. Rs1894720 polymorphism in MIAT increased susceptibility to age-related hearing loss by modulating the activation of miR-29b/SIRT1/PGC-1α signaling. J Cell Biochem., 2019, 120(4): 4975-4986

[137] LiY, LiA, WuJ, et al.. MiR-182-5p protects inner ear hair cells from cisplatin-induced apoptosis by inhibiting FOXO3a. Cell Death Dis., 2016, 7(9): e2362

[138] LaiR, CaiC, WuW, et al.. Exosomes derived from mouse inner ear stem cells attenuate gentamicin-induced ototoxicity in vitro through the miR-182-5p/FOXO3 axis. J Tissue Eng Regen Med., 2020, 14(8): 1149-1156

[139] ChenJ, LiuZ, YanH, et al.. miR-182 prevented ototoxic deafness induced by co-administration of kanamycin and furosemide in rats. Neurosci Lett., 2020, 723 134861

[140] LiuY, WuH, ZhangF, et al.. Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity by modulating the PTEN-PI3K-AKT axis. Biochem Cell Biol., 2021, 99(3): 385-395

[141] XieL, ZhouQ, ChenX, et al.. Elucidation of the Hdac2/Sp1/miR-204-5p/Bcl-2 axis as a modulator of cochlear apoptosis via in vivo/in vitro models of acute hearing loss. Mol Ther Nucleic Acids., 2021, 23: 1093-1109

[142] TanPX, DuSS, RenC, et al.. MicroRNA-207 enhances radiation-induced apoptosis by directly targeting Akt3 in cochlea hair cells. Cell Death Dis., 2014, 5(10): e1433

[143] Zhang YY, Xiong GY, Xie XX. MicroRNA-222 alleviates radiation-induced apoptosis by targeting BCL2L11 in cochlea hair cells. Biosci Rep. 2021;41(6):BSR20201397

[144] LiW, ZhangY, XuJ, et al.. Fasudil prevents neomycin-induced hair cell damage by inhibiting autophagy through the miR-489/NDP52 signaling pathway in HEI-OC1 cells. Exp Ther Med., 2022, 23(1): 43

[145] WangQ, LiW, CaiC, et al.. miR-153/KCNQ4 axis contributes to noise-induced hearing loss in a mouse model. J Physiol Sci., 2021, 71(1): 28

[146] DingL, WangJ. MiR-106a facilitates the sensorineural hearing loss induced by oxidative stress by targeting connexin-43. Bioengineered., 2022, 13(6): 14080-14093

[147] MiaoL, WangB, ZhangJ, et al.. A functional SNP in miR-625-5p binding site of AKT2 3’UTR is associated with noise-induced hearing loss susceptibility in the Chinese population. Environ Sci Pollut Res Int., 2021, 28(30): 40782-40792

[148] ChangTC, WentzelEA, KentOA, et al.. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell., 2007, 26(5): 745-752

[149] LinY, ShenJ, LiD, et al.. MiR-34a contributes to diabetes-related cochlear hair cell apoptosis via SIRT1/HIF-1α signaling. Gen Comp Endocrinol., 2017, 246: 63-70

[150] XiongH, ChenS, LaiL, et al.. Modulation of miR-34a/SIRT1 signaling protects cochlear hair cells against oxidative stress and delays age-related hearing loss through coordinated regulation of mitophagy and mitochondrial biogenesis. Neurobiol Aging., 2019, 79: 30-42

[151] JungSY, KimS, KangZ, et al.. Efficiency of a dexamethasone nanosuspension as an intratympanic injection for acute hearing loss. Drug Deliv., 2022, 29(1): 149-160

[152] KimJ, MaldonadoJ, PanDW, et al.. Semicircular canal drug delivery safely targets the inner ear perilymphatic space. JCI Insight., 2024, 9(21): e173052

[153] LinZ, XiangJ, SunX, et al.. Genome Sequencing Unveils the Role of Copy Number Variants in Hearing Loss and Identifies Novel Deletions With Founder Effect in the DFNB1 Locus. Human Mutation., 2024, 2024(1): 9517114

[154] RohacekAM, BebeeTW, TiltonRK, et al.. ESRP1 Mutations Cause Hearing Loss due to Defects in Alternative Splicing that Disrupt Cochlear Development. Developmental Cell., 2017, 43(3): 318-831.e5

[155] NakanoY, KellyMC, RehmanAU, et al.. Defects in the Alternative Splicing-Dependent Regulation of REST Cause Deafness. Cell., 2018, 174(3): 536-548.e21

[156] SnoeckxRL, HuygenPL, FeldmannD, et al.. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet., 2005, 77(6): 945-957

[157] QiuY, XieL, WangX, et al.. Abnormal Innervation, Demyelination, and Degeneration of Spiral Ganglion Neurons as Well as Disruption of Heminodes are Involved in the Onset of Deafness in Cx26 Null Mice. Neurosci Bull., 2024, 40(8): 1093-1103

[158] LiuY, WangL, YuanL, et al.. Hereditary deafness carrier screening in 9,993 Chinese individuals. Front Genet., 2023, 14: 1327258

[159] ZhangX, ZhengJ, XuH, et al.. UHRF1-induced connexin26 methylation is involved in hearing damage triggered by intermittent hypoxia in neonatal rats. Open Med (Wars)., 2023, 18(1): 20230650

[160] XuK, ChenS, XieL, et al.. The protective effects of systemic dexamethasone on sensory epithelial damage and hearing loss in targeted Cx26-null mice. Cell Death Dis., 2022, 13(6): 545

[161] ZhangD, TangZ, HuangH, et al.. Metabolic regulation of gene expression by histone lactylation. Nature., 2019, 574(7779): 575-580

[162] MerkuriF, RothsteinM, Simoes-CostaM. Histone lactylation couples cellular metabolism with developmental gene regulatory networks. Nat Commun., 2024, 15(1): 90

[163] IzzoLT, WellenKE. Histone lactylation links metabolism and gene regulation. Nature., 2019, 574(7779): 492-493

[164] LibertiMV, LocasaleJW. Histone Lactylation: A New Role for Glucose Metabolism. Trends Biochem Sci., 2020, 45(3): 179-182

[165] WuM, JiaG, LiuY, et al.. PKM2 controls cochlear development through lactate-dependent transcriptional regulation. Proc Natl Acad Sci U S A., 2025, 122(2): e2410829122

[166] Qiu L, Xu W, Lu X, et al. The HDAC6-RNF168 axis regulates H2A/H2A.X ubiquitination to enable double-strand break repair. Nucleic Acids Res. 2023;51(17):9166–9182.

[167] MattiroliF, PenengoL. Histone Ubiquitination: An Integrative Signaling Platform in Genome Stability. Trends Genet., 2021, 37(6): 566-581

[168] KazmierczakM, HarrisSL, KazmierczakP, et al.. Progressive Hearing Loss in Mice Carrying a Mutation in Usp53. J Neurosci., 2015, 35(47): 15582-15598

[169] WangB, WanL, SunP, et al.. Associations of genetic variation in E3 SUMO-protein ligase CBX4 with noise-induced hearing loss. Hum Mol Genet., 2022, 31(13): 2109-2120

[170] PouyoR, ChungK, DelacroixL, et al.. The ubiquitin-proteasome system in normal hearing and deafness. Hear Res., 2022, 426 108366

[171] WangW, SunY, ChenS, et al.. Impaired unfolded protein response in the degeneration of cochlea cells in a mouse model of age-related hearing loss. Exp Gerontol., 2015, 70: 61-70

[172] BaiX, WangM, NiuX, et al.. Effect of N-acetyl-cysteine treatment on sensorineural hearing loss: a meta-analysis. World J Otorhinolaryngol Head Neck Surg., 2022, 8(3): 205-212

[173] PanX, LiY, HuangP, et al.. Extracellular vesicles for developing targeted hearing loss therapy. J Control Release., 2024, 366: 460-478

[174] LiL, ChaoT, BrantJ, et al.. Advances in nanobased inner ear delivery systems for the treatment of sensorineural hearing loss. Adv Drug Deliv Rev., 2017, 108: 2-12

[175] WiseRA, HolbrookJT, CrinerG, et al.. Lack of Effect of Oral Sulforaphane Administration on Nrf2 Expression in COPD: A Randomized, Double-Blind, Placebo Controlled Trial. PLoS One., 2016, 11(11): e0163716

[176] MagnerM, ThorováK, ŽupováV, et al.. Sulforaphane Treatment in Children with Autism: A Prospective Randomized Double-Blind Study. Nutrients., 2023, 15(3): 718

[177] JosaE, BarrilG, RupertoM. Potential Effects of Bioactive Compounds of Plant-Based Foods and Medicinal Plants in Chronic Kidney Disease and Dialysis: A Systematic Review. Nutrients., 2024, 16(24): 4321

[178] Firoozi D, Masoumi SJ, Mohammad-Kazem Hosseini Asl S, et al. Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ulcerative colitis: a double-blind randomized controlled trial. Lipids Health Dis. 2024;23(1):216.

[179] KimYH, BagotM, Pinter-BrownL, et al.. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomized, controlled phase 3 trial. Lancet Oncol., 2018, 19(9): 1192-1204

[180] IsherwoodB, GonçalvesAC, CousinsR, et al.. The global hearing therapeutic pipeline: 2021. Drug Discov Today., 2022, 27(3): 912-922

Funding

Innovative Research Group Project of the National Natural Science Foundation of China(82271158)

RIGHTS & PERMISSIONS

The Author(s), under exclusive licence to Huazhong University of Science and Technology

Just Accepted

This article has successfully passed peer review and final editorial review, and will soon enter typesetting, proofreading and other publishing processes. The currently displayed version is the accepted final manuscript. The officially published version will be updated with format, DOI and citation information upon launch. We recommend that you pay attention to subsequent journal notifications and preferentially cite the officially published version. Thank you for your support and cooperation.